If a COVID-19 vaccine is approved and ready for distribution under President Donald Trump's administration, he said New York will not receive it because of Gov. Andrew Cuomo's remarks about how his administration has managed the pandemic.
Pharmacy
The price of a medication is a major factor in a patient’s willingness – or ability – to adhere to their prescribed treatment plan. But unlike nearly every other product a consumer might purchase in their typical day, the price…
An inhaled version of a drug commonly used to treat multiple sclerosis may help hospitalized COVID-19 patients recover faster, initial study data suggests, according to NBC News.
More information is needed to determine whether Eli Lilly's COVID-19 antibody drug, which received emergency authorization from the FDA Nov. 9, is safe and effective, and it's important for the public to understand that initial supply of the drug will…
While patients are sometimes left wondering why they feel a sudden drop in mood and motivation, the answer often stems from a new medication they've been prescribed.
Fluvoxamine, a drug that treats obsessive-compulsive disorder, could reduce the risk of respiratory deterioration and subsequent hospitalization in patients with early COVID-19, according to study results published Nov. 12 in the Journal of the American Medical Association.
HHS rolled out a federal vaccine allocation program, partnering with chain and community pharmacy networks that cover 60 percent of the nation's pharmacies, the department said Nov. 12.
Moderna's COVID-19 vaccine trial reached its goal to conduct its first interim analysis after it saw a significant increase in the rate of COVID-19 cases in the last week, the drugmaker said Nov. 11.
AstraZeneca's blood cancer drug, Calquence, failed in a phase 2 trial to help hospitalized COVID-19 patients recover, the drugmaker said Nov. 12.
Scientists expect that COVID-19 vaccines will cause flu-like symptoms, including muscle aches and fever, NBC News reported.